Literature DB >> 15452874

Generation of novel conditional and hypomorphic alleles of the Smad2 gene.

Ye Liu1, Maria H Festing, Mark Hester, John C Thompson, Michael Weinstein.   

Abstract

Smad2 is an intracellular mediator of the transforming growth factor beta signaling (TGFbeta) pathway. It has been previously shown that, in the mouse, ablation of functional Smad2 results in embryonic lethality due to gastrulation defects. To circumvent the early lethality and study the spatially and temporally specific functions of Smad2, we utilized the Cre-loxP system to generate a Smad2 conditional allele. Here we show that a conditional allele, Smad2(flox), was generated. In this allele, exons 9 and 10 are flanked by loxP sites and the gene is functionally wildtype. Cre-mediated recombination results in a deletion allele which phenocopies our previously reported Smad2(DeltaC) null mutation. To generate this conditional allele, we first made a targeted mutation which introduced a floxed neo cassette into intron 10. This allele (Smad2(3loxP)) functions hypomorphically when placed opposite a null allele, and unlike the other published Smad2 hypomorphic allele, can be maintained in the homozygous state. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452874     DOI: 10.1002/gene.20072

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  17 in total

1.  Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway.

Authors:  Liu-Ya Tang; Mary Heller; Zhaojing Meng; Li-Rong Yu; Yi Tang; Ming Zhou; Ying E Zhang
Journal:  J Biol Chem       Date:  2017-01-31       Impact factor: 5.157

2.  Redundant roles of SMAD2 and SMAD3 in ovarian granulosa cells in vivo.

Authors:  Qinglei Li; Stephanie A Pangas; Carolina J Jorgez; Jonathan M Graff; Michael Weinstein; Martin M Matzuk
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

3.  Ribosomal Proteins Rpl22 and Rpl22l1 Control Morphogenesis by Regulating Pre-mRNA Splicing.

Authors:  Yong Zhang; Monique N O'Leary; Suraj Peri; Minshi Wang; Jikun Zha; Simon Melov; Dietmar J Kappes; Qing Feng; Jennifer Rhodes; Paul S Amieux; David R Morris; Brian K Kennedy; David L Wiest
Journal:  Cell Rep       Date:  2017-01-10       Impact factor: 9.423

4.  Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation.

Authors:  Wenjun Ju; Atsushi Ogawa; Joerg Heyer; Dirk Nierhof; Liping Yu; Raju Kucherlapati; David A Shafritz; Erwin P Böttinger
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

5.  Smad1 and Smad8 function similarly in mammalian central nervous system development.

Authors:  Mark Hester; John C Thompson; Joseph Mills; Ye Liu; Heithem M El-Hodiri; Michael Weinstein
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

6.  Smad2/Smad3 in endothelium is indispensable for vascular stability via S1PR1 and N-cadherin expressions.

Authors:  Fumiko Itoh; Susumu Itoh; Tomomi Adachi; Kei Ichikawa; Yutaka Matsumura; Takahiro Takagi; Maria Festing; Takuya Watanabe; Michael Weinstein; Stefan Karlsson; Mitsuyasu Kato
Journal:  Blood       Date:  2012-04-12       Impact factor: 22.113

7.  TGF-β signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling.

Authors:  Brian C Cooley; Jose Nevado; Jason Mellad; Dan Yang; Cynthia St Hilaire; Alejandra Negro; Fang Fang; Guibin Chen; Hong San; Avram D Walts; Robin L Schwartzbeck; Brandi Taylor; Jan D Lanzer; Andrew Wragg; Abdalla Elagha; Leilani E Beltran; Colin Berry; Robert Feil; Renu Virmani; Elena Ladich; Jason C Kovacic; Manfred Boehm
Journal:  Sci Transl Med       Date:  2014-03-12       Impact factor: 17.956

8.  Follicle-stimulating hormone synthesis and fertility are intact in mice lacking SMAD3 DNA binding activity and SMAD2 in gonadotrope cells.

Authors:  Jérôme Fortin; Ulrich Boehm; Michael B Weinstein; Jonathan M Graff; Daniel J Bernard
Journal:  FASEB J       Date:  2013-12-05       Impact factor: 5.191

9.  Genetic evidence that SMAD2 is not required for gonadal tumor development in inhibin-deficient mice.

Authors:  Saneal Rajanahally; Julio E Agno; Roopa L Nalam; Michael B Weinstein; Kate L Loveland; Martin M Matzuk; Qinglei Li
Journal:  Reprod Biol Endocrinol       Date:  2010-06-21       Impact factor: 5.211

10.  Loss of Smad4 in the scleraxis cell lineage results in postnatal joint contracture.

Authors:  Saundra Y Schlesinger; Seongkyung Seo; Brian A Pryce; Sara F Tufa; Douglas R Keene; Alice H Huang; Ronen Schweitzer
Journal:  Dev Biol       Date:  2020-11-25       Impact factor: 3.148

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.